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Background : Colorectal carcinoma is one of the most common malignant 
neoplasm in this country . Its incidence is rising . New development in 
genetic studies has brought better understanding ofcolorectal carcinoma. 
·Newer treatment option has increased survival and quality of life . 
However the impact of this development has not been fully 
utilized especially in the rural areas in this country. 
Objective :To study the epidemiology of colorectal carcinoma in the 
Kuala Terengganu Hospital and the state ofTerengganu. To determine the 
clinical presentation of colorectal carcinoma in this hospital and to 
evaluate the mode of investigation and treatment received by the patients 
with colorectal carcinoma . The primary objective is to assess the 
treatment outcome in tenns of recurrence and survival . 
Methods : Between 19 87 to 1999 , 90 patients were treated in Hospital 
Kuala Terengganu for colorectal carcinoma. The sex, age , duration of 
symptom , the main and subsequent presenting problems , the type of 
special investigation and the location of the tumour were determined from 
patients record . Type of surgery , method of resection and presence of 
metastases were noted at the time of surgery . Specimens were sent to the 
pathologist for assessment of the tumour grade . 
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Survival duration were obtained from the patients record . 2 year survival 
rate was assessed and factors affecting survival were determined using 
nonparametric statistical analysis . 
Result: There was almost equal sex distribution among the patients. 53% 
of the patients were more then 60 years and young colorectal carcinoma 
consist of6%. Median duration of symptom was 4.3 months. 43.3% of 
the patients presented with intestinal obstruction and a almost equal 
number of them underwent emergency surgery. 68.7% of 
the patients were in Duke's C and D at presentation . At the time of 
presentation 24.4 % already had liver metastases . 30 day mortality and 
morbidity was 2.2 % and 11.1 % respectively . Overall swvival was 3 7.8 
%. Statistically Duke's staging, stage of metastases, initial clinical 
presentation , type of operation and use of adjuvant therapy 
significantly influences( p <0.05) the 2 year survival in this study. 
Conclusion : In this study , late presentation of colorectal carcinoma was 
common . Duke' s staging , initial clinical presentation , type of opemtion 
and the use of chemotherapy influences survival . A better follow up of 
colorectal carcinoma patient is needed. 
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III ABSTRAK 
Latar Belakang : Kancer kolon dan rektum adalah salah satu ketumbuhan 
malignan yang utama di negara ini . Kini insiden kanser in sedang 
meningkat . Kefahaman kita berkenaan penyakit kanser kolon dan rectum 
bertambah dengan perkembangan terbaru cialam bidang genetic. Kaedah 
perubatan yang terbaru membolehkan survival dan kualiti hidup 
ditingkatkan . Walaubagaimanapun perkembangan ini tidak dipergunakan 
sepenuhnya terutama di kawasan pendalaman di negara ini . 
Objektif: Kajian in bertujuan untuk mengetahui epidemiologi penyakit 
kanser kolon dan rectum di Hospital Kuala Terengganu dan di negeri 
Terengganu. Kajian inijuga melihat pada riwayat clinical penyakit ini dan 
menilai cara penyiasatan dan rawatan yang diterima oleh pesakit penyakit 
kanser kolon dan rectum . Objektif utama ialah untuk mengetahui kadar 
survival dan rekuren . 
Tatacara : Di antara tahun 1987 dan 1990 , seramai 90 pesakit kanser 
kolon dan rectum telah dirawat di Hospital Kuala Terengganu. Jantina, umur 
, jangkamasa gejala , riwayat penyakit yang utama , jenis penyiasatan yang 
digunakan dan lokasi kanser dipastikan melalui rekod pesakit. Jenis 
pembedahan , cara pembedahan dan metastasis tumor pada 
masa pembedahan dicatitkan . 
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Pengradan tumor oleh pakar patolo!:,ti juga dicatitkan . Jangkamasa pesakit 
hidup selepas pembedahan didapatkan melalui rekod pesakit. Kadar 
sutvival 2 tahun dikira dan faktor- faktor yang mempengaruhinya 
dipastikan melalui pengiraan statistik . 
Keputusan : Distribusi jan tina dikalangan penyakit adalah hampir sama rata . 
53 % pesakit berumur 53 tahun keatas dan 6 % adalah pesakit di bawah 40 
tahun. Kadar medianjangkamasa gejala adalah 4.3 bulan. 43.3 o/o pesakit 
datang dengan keadaan usus tersumbat dan jumlah yang sama menjalani 
pembedahan kecemasan. Semasa kali pertama pesakit dinilai, 68.7 o/o dari 
mereka berada dalam peringkat Dukes' C dan D . Pada masa yang sama 
24.4 % dari mereka sudah mempunyai metastasis di hepar . Kadar 
mortaliti dalam 30 hari dan mobiliti adalah 2.2 %dan 11/1 % masing-
masing . Kadar survival keseluruhan adalah 3 7.8 % . Klasifikasi Dukes' , 
peringkat metastasis ,gejala utama , jenis pembedahan dan pemberian 
terapi adjuvan mempengaruhi kadar survival dalam masa 2 tahun di 
dalam kajian ini . 
Kesimpulan: Dalam kajian ini pesakit kanserkolon dan rektum hanya 
datang untuk rawatan apabila penyakit mereka sudah merebak . 
Klasifikasi Dukes' , peringkat metastasis ,gejala utama , jenis pembedahan 
dan pemberian terapi adjuvant mempengaruhi kadar survival.Cara yang 
lebih baik diperlukan untuk mengikuti pesakit yang sudah menjalani 
rawatan. 
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In Malaysia more and more cases of colorectal carcinoma are being identified 
and treated. With establishment of a colorectal unit in Hospital Selayang and 
Hospital Universiti Kebangsaan Malaysia , proper research can be done 
on the Malaysian population in relation to colorectal carcinoma. As this 
country is a multiracial society , the differences in colorectal carcinoma 
within races may exist . This may be compounded with different levels of 
development in various parts of the country . 
This dissertation is a retrospective study of patients with colo rectal 
carcinomas seen in Hospital Kuala Terengganu, Kuala Terengganu from 
1987 to 1999. This hospital is a tertiacy referral center serving the rural 
population ofTerengganu state in the east coast of peninsular Malaysia. This 
study will assess the presentation and outcome of treatment of 
colorectal carcinoma in a general hospital where there is no specialized 
colorectal unit . From here we will know how to improve the service for 
the benefit of patients in the treatment of colorectal carcinoma . 
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2.0 LITERATURE REVIEW 
2.1 EPIDEMIOWGY 
Colorectal carcinoma is the fourth commonest form of cancer occurring 
world-wide , with an estimated 783,000 new cases diagnosed in 1990 . It affects 
men and women equally. World-wide, colorectal carcinoma represents 
9.4 % of all incident cancer in men and 10.1 % in women ( 3 ) . 
However it is not equally common throughout the world .If the 
western countries (North America ; Northern , southern and western 
Europe ; Austmlia ; New Zealand ) are combined , colorectal cancer 
represents 12.6% of man and 14.1 %of women of all incident cancers. 
Elsewhere colo rectal cancer represents 7. 7 % and 7.9 % 
of all incident cases in men and women respectively ( 3 ). 
Different populations worldwide experience different levels of colorectal 
cancer , and these levels change with time . Population living in one 
community also experience difrerent levels of colorectal cancers ( 4 ). 
Groups of migrants quickly lose the risk associated with their original home 
community and acquire the patterns of the new community , often starting 
within one generation of arrival( 4 ). 
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Ethnic and racial differences in colorectal cancer suggest that environmental 
factors play a major part in the etiology of the disease. In Israel male Jews 
born in Europe or the United States are at a higher risk of colon cancer 
compared to those born in Asia or Africa . Incidence in the offsprings 
now approaches or surpasses that in white people in the same 
population and is three or four times higher than Japanese in Japan . For 
these reason colorectal cancer is widely believed to be an" environmental" 
disease ( 4 ) . 
The incidence of colorectal carcinoma is a rising trend(5) . The incidence of 
colorectal cancer in eastern part of the Netherlands (700,000 inhabitants) 
was determined for two years, 1981 and 1996. In 1981 the diagnosis of 
colorectal cancer was seen in 232 patients in this region and in 1996, it was 
seen in 410 patients. The population remained almost stable during this 
time. Therefore, the incidence rose from 33 to 55 per 100,000 inhabitants 
from 1981 to 1996, respectively.ln 1981, 25 percent of the carcinomas were 
proximal (to the sigmoid colon); this increased to 37 percent in 1996. 
The location of the tumour is also more proximal now ( 6 ) . 
A similar trend is also observed in Bulgaria . It showed the 
incidence rate of colorectal carcinoma from 1985 to 1998 increased steadily 
from 22.14/100,000 to 37.18/100,000 (an increment ofl5.04/100,000). 
Most of the patients in this study ( 60 % ) were diagnosed at a later stage of 
the disease and this trend continues to 1998 ( 7 ) . 
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In Malaysia a similar trend is observed .Data from the ministry of health shows an 
increase of colorectal carcinoma rate from 8.1 % ( 1973 cases ) in 1987 to 
11.9 % {4215 cases in 1995 . Colorectal cancer was the third conunonest 
cancer death in Malaysia from 1987 to 1995 ( 8 ) . 
Rectal cancer is slightly more common in men, whereas there is a slight 
predominance of colon cancer in women( I). An American has 
approximately a 5 percent probability of developing colorectal cancer during 
a 70-year life span. Most cases of colorectal cancer are diagnosed in patients 
over the age of 50, and the incidence of the disease rises steadily after that 
age. Despite clear relationship with aging, colorectal cancer is not stricdy 
a disease of the elderly and between 6 to 8 percent of cases occur in 
individuals under the age of 40(1 ). In the Far East ,the incidence of colo rectal 
carcinoma is more in younger population compared to Western 
countries ( 9). 
In a retrospective study in Egypt, 38% of the colorectal cases were below the 
age of40 years old. The onset offiunilial and hereditary forms of the 
disease occurs at a much earlier age, typically around the third decade {10). 
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There are few studies in assessing the awareness of colo rectal carcinoma in 
an adult population. On assessment of public awareness ofcolorectal 
carcinoma , it was found that even in countries with high literacy rate only a 
minority ( I 1 % ) were aware of colorectal screening ( 1 1 ) . 
Similarly Nadel et ai noted only 22.9 %of Americans aged more than 
50 years old had gone for screening for colorectal carcinoma (12). 
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2.2 : ETIOLOGY AND RISK FACfORS 
2.2.1: Diet 
Evidence from epidemiological studies seems to show consistendy that 
intake of dietary fut and meat is positively related to the 
risk of colo rectal cancer . This evidence was obtained from ecological studies , 
animal experiments , and case control and cohort studies ( 13 ). 
In 1990 Willett et al published the results from the United States nurse 
health study involving a fullow-up of888,751 women aged 34-59 years who 
were without cancer or inflammatory bowel disease at recruitment . After 
adjustment for total energy intake , consumption of animal filt was found to 
be associated with increased risk of colon cancer. No association was found 
with vegetable mt . The relative risk in women who ate beef, pork , or lamb 
as a main dish every day was 2.49 compared with women reporting 
consumption less than once a month . The authors suggested that intake of 
animal fat increases the risk of colon cancer ( 13) . In the Asian population a 
similar trend could be found . Zhang et al (2002) in a study involving a rural 
region in China found that meat intake and saturated fat were prominent 
risk filctors for colorectal carcinoma (14). 
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Dietary fiber has been proposed as accounting for differences in the rates of 
colorectal cancer between Africa and westernized countries- on the basis 
that increased intake of dietary fiber may increase faecal bulk and reduce 
transit time . Many studies found no protective effect of fiber in cereals but 
have consistently found a protective effect of fiber in vegetables 
and fruits ( 13 , 14 ). 
Folate deficiency enhances intestinal carcinogenesis in several animal 
models. An increasing number of epidemiologic studies indicate that higher 
intakes of folate either from dietary sources or from supplements may lower 
the risk of colorectal adenoma and cancer( IS). More limited data also suggest 
that dietary methionine, which might also influence methylation, may have a 
similar protective role. High alcohol consumption, which has a strong 
antifolate effect, also has been related to higher risk of colorectal neoplasia 
The deleterious effects of alcohol are accentuated when folate or methionine 
intake is low (15). 
2.2.2 : Physical activity , body mass index , and energy intake 
Evidence from epidemiological studies show that men with high 
occupational or recreational physical activity seem to have a decreased risk 
of colon cancer. Giovannucci et al reported that activities from moderate 
intensity such as brisk walking is associated inversely with the risk of large 
adenoma (16).However there is no evidence to show a consistent association 
8 
between obesity and the risk of colo rectal cancer. 
2.2.3 : Hormone replacement therapy 
Increasing evidence supports an association between hormone replacement 
therapy and a reduced risk of colorectal cancer . The risk is halved with 
5 - 10 years of use . Whether this association is casual or is associated 
with some other factor is not known ( 17 ). 
2.2.4 : Familial risk factors 
A :family histocy of colorectal polyps is associated with increased risk of 
colo rectal carcinoma in other fiunily members . However 80 % of patients 
have " sporadic " colorectal carcinoma, with no familial risk factor identified. 
First degree relatives of patients with colorectal carcinoma are at a 
high risk to develop colorectal neoplasia. Orrom WJ et al(l990), studied 
colonoscopic finding in patients with colorectal carcinoma and found 
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that 21 % of them had neoplastic disease and another 28 % had adenoma beyond 
the splenic flexure(l9) . 25 % of these patients who were positive for adenoma are 
below 40 years old(l9) . Kesani et al (2002) reported 44 %patients under 40 
years old in their study had finnily history of colorectal carcinoma and these 
patients usually presents with more advanced stage of disease ( 18) . 
• Polyposis syndrome 
Familial syndrome takes the form of familial adenomatous 
polyposis syndromes (FAP). F AP accounts about 0.5% of all 
colonic carcinoma. It is autosomal dominant inherited propensity 
to develop numerous adenomas throughout the colon ' some of 
which in time will become malignant (2). The polyp appears at 
puberty and nearly all patients will have polyp by the early thirties. 
• Hereditaty non polyposis colonic carcinoma ( HNPCC ) 
This is more common but less obvious than F AP and is autosomal 
dominant inheritance . It is clinically similar to that of sporadic 
cases but more common in younger age groups. Lynch (1996) 
classified HNPCC into 2 subtypes ; site specific colon cancer 
where individuals of a family are susceptible to colonic cancer but 
not cancers of other organs (Lynch type I) ; cancer family 
syndrome where female members of the family are prone to breast 
and uterine cancer as well as colonic cancer (Lynch type 2) . The 
cancers occur predominantly on the right side of the colon and are 
of low malignancy in contrast to sporadic cases (20). 
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2.2.5 : Molecular Genetics 
Colorectal adenoma carcinoma sequence 
One of the most important concepts in colorectal carcinoma to emerge in 
recent years has been the adenoma- carcinoma sequence , a term that 
describes the stepwise progression from normal to dysplastic epithelium to 
carcinoma associated with the accumulation of multiple clonally selected 
genetic alterations. 
Although the adenoma- carcinoma sequence has not been proven directly , 
there is considerable indirect evidence to support it from a range of 
epidemiological, clinical, histopathological and genetic studies. 
1. Epidemiological and clinico-pathological evidence - age distribution 
cwves for adenoma and carcinoma show that the prevalence of both 
increases with increasing age , but adenomas are recognized and their 
prevalence peaks at least 5 years earlier than that of colorectal 
carcinomas ( 21 ). In surgical resection specimens and during 
endoscopic examination adenomas are found to coexist with carcinoma 
in about 30 % of cases and patients who have colo rectal carcinoma and 
simultaneous adenomas have been shown to have increased risk of 
synchronous and metachronous carcinoma ( 22 ). 
I I 
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The anatomical distribution of adenomas and carcinoma is similar , occurring 
more frequendy distal to splenic flexure; adenoma ofleft colon often 
contain more severe dysplasia or invasive adenocarcinoma ( 23 ). 
Finally endoscopic removal of adenomatous polyps appear to reduce the 
long term risk of colorectal carcinoma ( 24 ). 
2. Genetic evidence - the concept of carcinoma arising from genetic 
abnormality has existed fur many years. In colo rectal carcinoma, the 
genes of interest that are involved in genetic alterations may be classified 
into three types : oncogenes , tumour suppressor genes and DNA repair 
genes ( 25 ). In 1990 Fearon and Vogelstein proposed a genetic model for 
colorectal tumorigenesis ( 26). This model postulated that mutational 
activation of oncogenes , coupled with mutational inactivation of tumour 
suppressor genes , leads to the development of colorectal tumours . Although 
these alterations occur in sequence , it is the total accumulation of changes 
which is important. The key oncogene in this model was ras and the key 
tumour suppressor genes were proposed residing on chromosome 5q , l7p , and 
18q . However , now there is an alternative pathway in a subset of colorectal 
tumours that less frequently involves the above mentioned genes and often 
involves mismatched repair genes(26,27) 
• Adenomatous Polyposis coli ( APC ) -is one mutation known to 
occur early in the adenoma- carcinoma sequence affects the 
adenomatous polyposis coli ( APC) tumour suppressor gene 
located on chromosome 5q21 . 
Mutation of this gene is responsible for familial adenomatous 
polyposis (F AP) , an autosomal dominant disorder characterized 
by development of thousands ofcolorectal adenomas appearing in 
adolescence or early adulthood ( 28 ). If untreated it 
leads to colorectal carcinoma at the third or fourth decade of life. 
APC mutation or allelic losses of Sq are observed in 40 - 80 % of 
colorectal carcinomas and are fomtd at a similar frequency in 
adenomas ( 29 ) . 
• K-ras- Activating mutation ofthe oncogene K-ras also occurs 
early in the adenoma- carcinoma sequence . This gene is involved 
in signal transduction of regulatory pathways critical for normal 
proliferation and differentiation ( 30 ) . 
Activating K-ras mutation occurs in 35 - 42 % of colorectal 
careinoma and were also observed at similar frequency in large 
adenomas . It is also being investigated as a potential predictors of 
metachronous adenomas ( 29 , 32 ). 
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• P53 -located on the short ann of chromosome 17 , p53 was 
initially implicated in colorectal carcinoma as a result of the 
frequent loss of 17 p in allelic loss and cytogenic studies . It 
functions as a sequence specific DNA binding protein and 
transcription factor controlling the expression of a large number of 
genes (29 , 33 ). It has been labeled as the 
guardian of the genome because of its ability to block cell 
proliferation in the presence of DNA damage , to stimulate DNA 
repair and to promote apoptotic cell death if repair is insufficient . 
The alteration in p53 or 17p allelic loss has been reported to occur 
in 50- 75 % of adenocarcinoma and in 4 - 26 % of adenoma 
(29 ,31). 
• 18q loss - this is the second most common region of allelic loss 
in colorectal carcinoma occuning in about 70 % of cases . 18q 
loss is also observed in 10-30% of early adenomas and it is 
raised to 60 % in late adenomas . The original tumour suppressor 
gene in this region was thought to be the " deleted in colorectal 
cancer" (29, 31 , 34). 
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Microsatellite instability 
A recently proposed alternative pathway for a subset of colorectal tumours is 
characterized by the presence ofmicrosatellite instability (MSI). 
Microsatellite are a type ofDNA that consists of tandem repeats, usually 
between one and five base pairs , repeated many times (3 5 ). 
Hundreds ofthousands ofmicrosatellites are found interspersed throughout 
the human genome and are particularly prone to errors during DNA 
replication . 
Such errors are usually repaired by mismatch repair (MMR) 
proteins but , in the absence of competent MMR function , microsatellite 
eiTOr accumulates . When these errors are sufficiently frequent , the term 
MSI or replication error positive is applied . 
Thus MSI can be interpreted as a marker for a state ofhypermutability (36,37). 
MSI is obsetVed in almost all adenocarcinomas from patients with hereditary 
non -polyposis colorectal cancer (HNPCC) that occurs in 1 0 - 15 % of 
sporadic colorectal carcinoma (38). The presence ofMSI in 
sporadic colorectal carcinoma and HNPCC correlates significantly with a 
number of clinical and pathological features including proximal location , 
diploid DNA content , a favourable Dukes' staging , improved survival 
and the presence of a Crohn~s like inflammatory infiltrate (38, 39,42). 
15 
The presence of MSI has a favorable genetic prognostic markers for 
colo rectal carcinoma and may imply an increased risk of a second primary 
tumour in the colon or an endometrial tumour in the patient or family 
members. 
In the future this genetic testing will come into common use for 
the prognosis of colorectal carcinoma and will affect their management 
( 40 '41 ). 
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2J:CL~CALPRESENTATION 
Patients with colonic and rectal carcinoma have a broad range of clinical 
presentation that can be sub-classified according to the anatomic site of the 
primary . In the earliest stage they may be asymptomatic . Caecal and right 
sided tumours accounts for 20 % of large bowel carcinoma , 70 % occur 
distal to the splenic flexure , and about 45 % are at or below the recto-
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sigmoid junction ( 1,2 ). Kullavanijaya (2002) in a retrospective analysis reported 
distal colorectal carcinoma was about 72 % ( 45) . However there is a shift from 
left sided toward right sided carcinoma confirmed by epidemiological study 
by Cucino et al ( 44 ). Bowel habit change , weight loss and mucous 
bloody dianhea are the most common presentations( 45). 
Caecal and right sided carcinoma 
Right sided tumours are often remarkably silent and many patients present 
with only the symptom and signs of iron deficiency from protracted occult 
blood loss .Preoperative anaemia was the most common finding with right sided 
tumour present in 58% of patients ( 46). As the lumen becomes 
narrowed the patient complains of intermittent colic , centrally or in the right 
iliac fossa, which is often post-prandial, stimulated by gastro-colic reflex. 
Typical distal ileal obstruction occurs if the tumour blocks the ileo-caecal 
valve causing incompetence of the valve characterized by progressive 
central abdominal colicky pain , faeculent vomiting and abdominal 
distension . Not infrequently a palpable mass may be the presenting 
symptom. 
Patients can occasionally present with acute appendicitis when the carcinoma 
occludes the appendicular orifice and produce acute inflammation or from a 
perforated carcinoma . 
The tumour may penetiate the bowel wall , producing a sealed perforation 
and fonnation of abscess on the psoas muscle which may manifest as painful 
right iliac fossa mass ( 2 ). 
Left sided and sigmoid colon 
Patients commonly present with change of bowel habit, often constipation 
alternating with diarrhea , usually accompanied by lower abdominal colicky 
pain . The symptoms progressively become worse and later patients may 
develop obstruction. 
Change in bowel habit is often accompanied by passage of altered blood , 
sometimes mucus , in the stool or on its surfilce . 
Occasionally they may present as frank per-rectal bleeding which is usually 
intermittent and brisk . 
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A few patients may have localized left iliac fossa pain associated with a 
palpable mass . At the splenic flexure presence of tumour must be 
distinguished from a palpable left kidney . 
Some patients have few symptoms until they present with intestinal 
obstruction . If the ileo-caecal valve is incompetent the obstructed large 
bowel decompresses into the small bowel and produces a mixed picture of 
small and large bowel obstruction . 
If the ileo-caecal valve is competent , the caecum will be distended and this 
will lead to perforation . Occasionally the tumour itself can perforate and 
present as diffuse peritonitis . Perforation of colon associated with 
malignancy is reported to be between 3 - 8 % ( 43 ) . 
At times the tumour may become attached to the adjacent organ such as 
lateral abdominal wall , uterus , bladder and vagina . The tumour may 
perforate the organs and present as a fistula . Colonic carcinoma is the 
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second most common cause of colovesical fistula after diverticular disease ( 1 , 2 ). 
Rectal carcinoma 
Most patients with rectal carcinoma present with per-rectal bleeding and 
change ofbowel habits . The blood may be dark in color, mixed with stool 
or bright red separate fiom the stool. For this reason patients attribute it to 
hemonhoid, a symptom produced by advanced rectal tumour (1 ,2). 
The patients also may have tenesmus and spurious diarrhea . 
Penetration of tumour to the sacrum will produce perineal pain 
shooting down the thigh . Intestinal obstruction is a late sign , indicating 
advanced disease {1). 
Metastatic symptoms from colorectal carcinoma are rare presentations. 
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2.4 PATHOLOGY 
The vast majority ofcolorectal carcinomas are adenocarcinoma. They may be well 
differentiated ( 20 % ) , moderately differentiated ( 60 % ) or poorly 
differentiated ( 20 % ) . The epithelial cells lining the glands show nuclear 
stratification , pleomorphism , hyperchromasia and high mitotic rate ( 4 7 ). If large 
amount of mucin is produced by the tumour and more then 70 % of the tumour is 
occupied by mucin lakes , it is classified as a mucinous carcinoma ( 4 7 ). 
Lee YS( 1988 ) in a study of large bowel carcinoma in Singapore noted that non 
mucinous carcinoma is by fur the commonest histological type ( 74.7%) followed 
by mucinous carcinoma ( 20.7 % ) . Other histological type were relatively 
uncommon ( 48 ). They include carcinoid tumours (1.8 % ) , signet ring cell 
carcinoma ( 1.5 % ) , squamous cell carcinoma ( 0. 7 % ) , undifferentiated 
carcinoma ( 0.4%) and adenosquamous carcinoma ( 0.2%). The proportion of 
mucinous carcinoma was greatest among the Malay and Indian ( 48 ). The right 
colon had a greater proportions of poorly differentiated carcinoma than the left 
colon ( 48 , 49 , 50). This tendency is more evident in the female . Mucinous 
carcinoma occurs more frequent in younger age group and in populations with with 
low risk for colorectal carcinoma ( 48 , 49 , 50 ). A greater proportion of mucinous 
caroinoma located in the rectum and right colon ( 48 , 49 , 50 ). Mucinous 
carcinoma usually present in more advanced stage and have a low curative resection 
rate ( 49 ). The overall survival rate of patients with mucinous carcinoma is worse 
than that of non-mucinous carcinoma ( 48 , 49 , 50 ) . 
2.5: STAGING 
Several staging methods are in use throughout the world, and each has its own 
strengths and weaknesses. The most commonly used are Duke's 
classification, American Joint Committee on Cancer (AJCC) and the Union 
Intemationale Contre Cancer (UICC) TNM classification. Based on 
AJCC/UICC , several variations developed but the most commonly used is 
pathological (pTNM) staging (51 , 52). 
Dukes' classification introduced in 1929, has the advantage of simplicity but 
it lacks precision. It does not reflect accurately the 
depth of tumour penetration, the extent of spread outside the bowel wall, the 
number oflymph nodes involved and the presence or absence of metastases. 
Staging gives information about prognosis in general, but particularly 
indicates the probability of occult hepatic metastases, which is the major 
fitctor affecting swvival. 
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Table 1: 
Dukes' Classification 
A Intramucosal 
B Tumour involving the bowel wall 
C Regional lymph node involvement( lymph nodes around the superior and 
inferior mesenteric vessels ; excluding para-aortic nodes ) 
D Adjacent organs or distant metastasis( including para-aortic nodes ) 
Table: 2 
AJCauiCC TNM pathologic staging, 1997 version 
PrimaJy tumour (T) 
TX Primary twnour cannot be assessed 
TO No evidence of primary tumour 
Tis Carcinoma in-situ: intraepithelial or invasion of lamina propria 
Tl Tumour invades submucosa 
T2 Tumour invades muscularis propria 
T3 Tumour invades through the muscularis propria into the 
sub serosa, or non peritonealized pericolic or perirectal tissues 
T 4 Tumour directly invades other organs or structures, and/or 
perforates visceral peritoneum 
Regional Lvmph Node 
NX Regional Lymph nodes cannot be assessed 
NO No regional lymph node metastasis 
Nl Metastasis in one to three regional lymph nodes 
N3 Metastasis in four or more regional lymph nodes 
Distant Metastasis 
MX Distant metastasis cannot be assessed 
MO No distant metastasis 
M 1 Distant metastasis 
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Table: 3 
Stage Groupine 
AJCC/lHCC 
Stage 0 Tis NO MO 
Stage 1 Tl NO MO 
T2 NO MO 
Stage2 T3 NO MO 
T4 NO MO 
Stage 3 AnyT Nl MO 
AnyT N2 MO 
Stage4 AnyT AnyT Ml 
Table: 4 
Common ' T stage ' penetration 
Colon Transverse , Sigmoid . Recto-sigmoid 
pTl invasive into submucosa 
p T2 muscularis propria 
pT3 through the muscle , not through serosa 
pT4 through the mucosa 
pT4 into contiguous organ 
Extra-peritoneum rectum 
pTl Invasive into the submucosa 
pT2 Muscularis propria 
pT3 Transmural into peri-rectal :fat 
pT4 lntocontigous organ 
Dukes' 
A 
B 
c 
D 
For this dissertation Duke's Classification was used as the staging system . 
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